Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
Pediatr Diabetes
; 19(5): 945-954, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-29473705
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Alpha 1-Antitrypsin
/
Diabetes Mellitus, Type 1
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
Language:
En
Journal:
Pediatr Diabetes
Year:
2018
Document type:
Article